Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hemostatic abnormalities in ischemic stroke]

M Misz1, L Oláh, J Kappelmayer

  • 1Debreceni Orvostudományi Egyetem Neurológiai Klinika, Klinikai Biokémiai és Molekuláris Patológiai Intézet.

Orvosi Hetilap
|November 12, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Search for New Physics in Jet Multiplicity Patterns of Multilepton Events at sqrt[s]=13  TeV.

Physical review letters·2025
Same author

Reweighting simulated events using machine-learning techniques in the CMS experiment.

The European physical journal. C, Particles and fields·2025
Same author

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Journal of medical economics·2023
Same author

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022
Same author

Practice recommendations for neurovascular ultrasound investigations of acute stroke patients in the setting of the COVID-19 pandemic: an expert consensus from the European Society of Neurosonology and Cerebral Hemodynamics.

European journal of neurology·2020
Same journal

[The application of artificial intelligence in healthcare: benefits, challenges, and issues of responsibility].

Orvosi hetilap·2026
Same journal

[Long-COVID syndrome and lung-specific abnormalities following COVID-19].

Orvosi hetilap·2026
Same journal

[Validation of the Vaccination Attitudes Examination (VAX) scale in Hungary].

Orvosi hetilap·2026
Same journal

Orvosi hetilap·2026
Same journal

[The Hungarian short version and psychometric properties of the Activities-specific Balance Confidence Scale for assessing fall risk].

Orvosi hetilap·2026
Same journal

[Hungarian primary care: facts, problems and expectations].

Orvosi hetilap·2026
See all related articles

Young stroke patients show elevated thrombin generation and reduced fibrinolysis, indicating hypercoagulability. These hemostatic abnormalities, including thrombin-antithrombin (TAT) and prothrombin fragment 1+2 (F1+2), are key indicators for assessing stroke progression.

Area of Science:

  • Neurology
  • Hematology
  • Biochemistry

Context:

  • Cerebral circulatory disturbances, or stroke, in young individuals often lack clear diagnostic indicators via Doppler and angiography.
  • Understanding the underlying hemostatic abnormalities is crucial for early diagnosis and management.

Purpose:

  • To investigate hemostatic abnormalities, including coagulation activation and fibrinolysis markers, in young stroke patients without apparent stroke indicators on initial imaging.
  • To assess the role of thrombin generation, secondary fibrinolysis, and specific inhibitors like PAI-1 and Lp(a) in young stroke development.

Summary:

  • In the acute phase, young stroke patients exhibited significantly elevated thrombin-antithrombin (TAT) and prothrombin fragment 1+2 (F1+2) levels, suggesting dominant thrombin generation over secondary fibrinolysis.

Related Experiment Videos

  • Reduced in vitro fibrinolytic capacity correlated with lipoprotein(a) [Lp(a)] levels, but not with plasminogen activator inhibitor (PAI-1).
  • Distinct patterns of elevated markers (F1+2 in TIA/acute, TAT in stroke) were observed across patient groups.

    • Impact:

    • The study highlights the potential of hemostatic markers to quantify hypercoagulability and endogenous lysis in young stroke patients.
    • These findings are important for judging disease progression and guiding therapeutic strategies in cerebrovascular diseases.